bpc-157 counters oxidative stress Wolverine Blend (BPC-157, TB-500) Modulatory effects of BPC 157

Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon

Considering the short half-life nature of peptides, of which BPC-157 is an example, it can initially be that the agent is generally safe

ACS Nano 9(5):53645371 Wu F, Yang K, Li Q, Shah TR, Ahmad M, Zhang QY et al (2021a) Biomass-derived 3D magnetic porous carbon fibers with a helical/chiral structure toward superior microwave absorption

This means BPC-157's primary superpower is angiogenesis the rapid creation of new blood vessels